Abstract:
A panel of life-sciences experts--Don deBethizy, CEO of Targacept, Inc., a Winston-Salem company developing treatments for central nervous system disorders; Jan Turek, CEO of Biolex Therapeutics, Inc., a Pittsboro drug-maker; Jeff Clark, managing general partner of the Aurora Funds, a Durham venture-capital company; Robert McMahan, Gov. Michael Easley�s science adviser; and Sam Taylor, president of the North Carolina Biosciences Organization, a trade group based in the Research Triangle Park--discuss the state of biomanufacturing in North Carolina, whether the state can compete in this market, and the new North Carolina Research Campus being built in Kannapolis.